Gross Profit On Sales تغيير تاريخ
Adcock Ingram Holdings ZAR 1.54B 73.26M 2024-12
Alaunos Therapeutics -1127000 1.11M 2024-09
Avita Medical AUD 16.13M 3.05M 2024-12
Celltrion KRW 442.87B 100.93B 2025-03
Cspc Pharmaceutical CNY 4.71B 391.66M 2025-03
Dianthus Therapeutics 1.16M 164K 2025-03
Divis Laboratories Ltd 14.54B 1.5B 2025-06
IQVIA Holdings USD 1.05B 251M 2025-06
Kangmei Pharma CNY 223.73M 38.54M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 14.72M 1.36M 2024-12
Moderna USD 18M 1000K 2025-06
Organigram Holdings CAD 1.05M 67.34M 2024-12
Organon & Co USD 874M 33M 2025-06
Pharma Mar EUR 53.61M 18.15M 2025-06
Qiagen NV USD 334.29M 25.6M 2025-06
Revvity USD 392.56M 17.01M 2025-06
Sartorius EUR 416.2M 14.8M 2025-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tectonic Therapeutic 0 0 2025-03
Tilray USD 61.22M 1.51M 2024-11
Viatris USD 1.33B 98.1M 2025-06
Xeris Pharmaceuticals USD 50.62M 9.95M 2024-12
Zz Pientze Pharmaceu 1.39B 632.84M 2025-03


Dianthus Therapeutics الربح الإجمالي على المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.